An adenovirus DNA replication factor, but not incoming genome complexes, targets PML nuclear bodies

Journal of Virology

Volumn 90, Issue 3, 2016, Pages 1657-1667

  Komatsu, Tetsuro ^a,b   Nagata, Kyosuke ^b   Wodrich, Harald ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; DNA REPLICATION FACTOR; NUCLEIC ACID BINDING PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; UNCLASSIFIED DRUG; AUTOANTIGEN; CELL NUCLEUS ANTIGEN; DBP PROTEIN, ADENOVIRUS; MACROMOLECULE; NUCLEAR PROTEIN; PML PROTEIN, HUMAN; PROTEIN BINDING; SP100 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN THIOLESTERASE; USP7 PROTEIN, HUMAN; VIRAL PROTEIN;

ADENOVIRIDAE; ARTICLE; CONTROLLED STUDY; DNA REPLICATION; DNA VIRUS; GENE LOCATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOLECULAR IMAGING; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TARGETING; VIRUS GENOME; VIRUS REPLICATION; CELL LINE; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; HOST PATHOGEN INTERACTION; IMAGE PROCESSING; MACROMOLECULE; METABOLISM; PHYSIOLOGY;

ADENOVIRIDAE; ANTIGENS, NUCLEAR; AUTOANTIGENS; CELL LINE; DNA REPLICATION; DNA-BINDING PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MACROMOLECULAR SUBSTANCES; MICROSCOPY, FLUORESCENCE; NUCLEAR PROTEINS; OPTICAL IMAGING; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN BINDING; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84958073943     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02545-15     Document Type: Article

References (44)

1. Lallemand-Breitenbach V, de Thé H. 2010. PML nuclear bodies. Cold Spring Harb Perspect Biol 2:a000661. http://dx.doi.org/10.1101/cshperspect.a000661.
2. Ching RW, Dellaire G, Eskiw CH, Bazett-Jones DP. 2005. PML bodies: a meeting place for genomic loci? J Cell Sci 118:847-854. http://dx.doi.org/10.1242/jcs.01700.
3. Schreiner S, Wodrich H. 2013. Virion factors that target Daxx to overcome intrinsic immunity. J Virol 87:10412-10422. http://dx.doi.org/10.1128/JVI.00425-13.
4. Weidtkamp-Peters S, Lenser T, Negorev D, Gerstner N, Hofmann TG, Schwanitz G, Hoischen C, Maul G, Dittrich P, Hemmerich P. 2008. Dynamics of component exchange at PML nuclear bodies. J Cell Sci 121: 2731-2743. http://dx.doi.org/10.1242/jcs.031922.
5. Ishov AM, Maul GG. 1996. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol 134:815-826. http://dx.doi.org/10.1083/jcb.134.4.815.
6. Sourvinos G, Tavalai N, Berndt A, Spandidos DA, Stamminger T. 2007. Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells. J Virol 81:10123-10136. http://dx.doi.org/10.1128/JVI.01009-07.
7. Bell P, Lieberman PM, Maul GG. 2000. Lytic but not latent replication of Epstein-Barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J Virol 74:11800-11810. http://dx.doi.org/10.1128/JVI.74.24.11800-11810.2000.
8. Day PM, Baker CC, Lowy DR, Schiller JT. 2004. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A 101:14252-14257. http://dx.doi.org/10.1073/pnas.0404229101.
9. Everett RD. 2013. The spatial organization of DNA virus genomes in the nucleus. PLoS Pathog 9:e1003386. http://dx.doi.org/10.1371/journal.ppat.1003386.
10. Everett RD. 2006. Interactions between DNA viruses, ND10 and the DNA damage response. Cell Microbiol 8:365-374.
11. Boutell C, Sadis S, Everett RD. 2002. Herpes simplex virus type 1 immediate-early protein ICP0 and its isolated RING finger domain act as ubiquitin E3 ligases in vitro. J Virol 76:841-850. http://dx.doi.org/10.1128/JVI.76.2.841-850.2002.
12. Everett RD, Freemont P, Saitoh H, Dasso M, Orr A, Kathoria M, Parkinson J. 1998. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110-and proteasome-dependent loss of several PML isoforms. J Virol 72:6581-6591.
13. Everett RD, Murray J. 2005. ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J Virol 79:5078-5089. http://dx.doi.org/10.1128/JVI.79.8.5078-5089.2005.
14. Lukashchuk V, Everett RD. 2010. Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx. J Virol 84:4026-4040. http://dx.doi.org/10.1128/JVI.02597-09.
15. Everett RD, Rechter S, Papior P, Tavalai N, Stamminger T, Orr A. 2006. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol 80:7995-8005. http://dx.doi.org/10.1128/JVI.00734-06.
16. Everett RD, Parada C, Gripon P, Sirma H, Orr A. 2008. Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. J Virol 82:2661-2672. http://dx.doi.org/10.1128/JVI.02308-07.
17. Schreiner S, Wimmer P, Sirma H, Everett RD, Blanchette P, Groitl P, Dobner T. 2010. Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells. J Virol 84:7029-7038. http://dx.doi.org/10.1128/JVI.00074-10.
18. Berscheminski J, Wimmer P, Brun J, Ip WH, Groitl P, Horlacher T, Jaffray E, Hay RT, Dobner T, Schreiner S. 2014. Sp100 isoform-specific regulation of human adenovirus 5 gene expression. J Virol 88:6076-6092. http://dx.doi.org/10.1128/JVI.00469-14.
19. Tavalai N, Papior P, Rechter S, Stamminger T. 2008. Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J Virol 82:126-137. http://dx.doi.org/10.1128/JVI.01685-07.
20. Tavalai N, Papior P, Rechter S, Leis M, Stamminger T. 2006. Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J Virol 80:8006-8018. http://dx.doi.org/10.1128/JVI.00743-06.
21. Mitchell AM, Hirsch ML, Li C, Samulski RJ. 2014. Promyelocytic leukemia protein is a cell-intrinsic factor inhibiting parvovirus DNA replication. J Virol 88:925-936. http://dx.doi.org/10.1128/JVI.02922-13.
22. Erickson KD, Bouchet-Marquis C, Heiser K, Szomolanyi-Tsuda E, Mishra R, Lamothe B, Hoenger A, Garcea RL. 2012. Virion assembly factories in the nucleus of polyomavirus-infected cells. PLoS Pathog 8:e1002630. http://dx.doi.org/10.1371/journal.ppat.1002630.
23. Stepp WH, Meyers JM, McBride AA. 2013. Sp100 provides intrinsic immunity against human papillomavirus infection. mBio 4:e00845-13. http://dx.doi.org/10.1128/mBio.00845-13.
24. Giberson AN, Davidson AR, Parks RJ. 2012. Chromatin structure of adenovirus DNA throughout infection. Nucleic Acids Res 40:2369-2376. http://dx.doi.org/10.1093/nar/gkr1076.
25. Perez-Berna AJ, Marion S, Chichon FJ, Fernandez JJ, Winkler DC, Carrascosa JL, Steven AC, Siber A, San Martin C. 2015. Distribution of DNA-condensing protein complexes in the adenovirus core. Nucleic Acids Res 43:4274-4283. http://dx.doi.org/10.1093/nar/gkv187.
26. Komatsu T, Haruki H, Nagata K. 2011. Cellular and viral chromatin proteins are positive factors in the regulation of adenovirus gene expression. Nucleic Acids Res 39:889-901. http://dx.doi.org/10.1093/nar/gkq783.
27. Haruki H, Gyurcsik B, Okuwaki M, Nagata K. 2003. Ternary complex formation between DNA-adenovirus core protein VII and TAF-Iβ/SET, an acidic molecular chaperone. FEBS Lett 555:521-527. http://dx.doi.org/10.1016/S0014-5793(03)01336-X.
28. Puntener D, Engelke MF, Ruzsics Z, Strunze S, Wilhelm C, Greber UF. 2011. Stepwise loss of fluorescent core protein V from human adenovirus during entry into cells. J Virol 85:481-496. http://dx.doi.org/10.1128/JVI.01571-10.
29. Komatsu T, Dacheux D, Kreppel F, Nagata K, Wodrich H. 2015. A method for visualization of incoming adenovirus chromatin complexes in fixed and living cells. PLoS One 10:e0137102. http://dx.doi.org/10.1371/journal.pone.0137102.
30. Pombo A, Ferreira J, Bridge E, Carmo-Fonseca M. 1994. Adenovirus replication and transcription sites are spatially separated in the nucleus of infected cells. EMBO J 13:5075-5085.
31. Dekker J, Kanellopoulos PN, Loonstra AK, van Oosterhout JAWM, Leonard K, Tucker PA, van der Vliet PC. 1997. Multimerization of the adenovirus DNA-binding protein is the driving force for ATPindependent DNA unwinding during strand displacement synthesis. EMBO J 16:1455-1463. http://dx.doi.org/10.1093/emboj/16.6.1455.
32. Ching W, Koyuncu E, Singh S, Arbelo-Roman C, Hartl B, Kremmer E, Speiseder T, Meier C, Dobner T. 2013. A ubiquitin-specific protease possesses a decisive role for adenovirus replication and oncogenemediated transformation. PLoS Pathog 9:e1003273. http://dx.doi.org/10.1371/journal.ppat.1003273.
33. Wodrich H, HenaffD, Jammart B, Segura-Morales C, Seelmeir S, Coux O, Ruzsics Z, WiethoffCM, Kremer EJ. 2010. A capsid-encoded PPxYmotif facilitates adenovirus entry. PLoS Pathog 6:e1000808. http://dx.doi.org/10.1371/journal.ppat.1000808.
34. Schreiner S, Martinez R, Groitl P, Rayne F, Vaillant R, Wimmer P, Bossis G, Sternsdorf T, Marcinowski L, Ruzsics Z, Dobner T, Wodrich H. 2012. Transcriptional activation of the adenoviral genome is mediated by capsid protein VI. PLoS Pathog 8:e1002549. http://dx.doi.org/10.1371/journal.ppat.1002549.
35. Komatsu T, Nagata K. 2012. Replication-uncoupled histone deposition during adenovirus DNA replication. J Virol 86:6701-6711. http://dx.doi.org/10.1128/JVI.00380-12.
36. Bérubé NG, Healy J, Medina CF, Wu S, Hodgson T, Jagla M, Picketts DJ. 2008. Patient mutations alter ATRX targeting to PML nuclear bodies. Eur J Hum Genet 16:192-201. http://dx.doi.org/10.1038/sj.ejhg.5201943.
37. Lovejoy CA, Li W, Reisenweber S, Thongthip S, Bruno J, de Lange T, De S, Petrini JHJ, Sung PA, Jasin M, Rosenbluh J, Zwang Y, Weir BA, Hatton C, Ivanova E, Macconaill L, Hanna M, Hahn WC, Lue NF, Reddel RR, Jiao Y, Kinzler K, Vogelstein B, Papadopoulos N, Meeker AK. 2012. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet 8:e1002772. http://dx.doi.org/10.1371/journal.pgen.1002772.
38. Schreiner S, Bürck C, Glass M, Groitl P, Wimmer P, Kinkley S, Mund A, Everett RD, Dobner T. 2013. Control of human adenovirus type 5 gene expression by cellular Daxx/ATRX chromatin-associated complexes. Nucleic Acids Res 41:3532-3550. http://dx.doi.org/10.1093/nar/gkt064.
39. Gonzalez R, Huang W, Finnen R, Bragg C, Flint SJ. 2006. Adenovirus E1B 55-kilodalton protein is required for both regulation ofmRNAexport and efficient entry into the late phase of infection in normal human fibroblasts. J Virol 80:964-974. http://dx.doi.org/10.1128/JVI.80.2.964-974.2006.
40. Bishop CL, Ramalho M, Nadkarni N, May Kong W, Higgins CF, Krauzewicz N. 2006. Role for centromeric heterochromatin and PML nuclear bodies in the cellular response to foreign DNA. Mol Cell Biol 26:2583-2594. http://dx.doi.org/10.1128/MCB.26.7.2583-2594.2006.
41. Haruki H, Okuwaki M, Miyagishi M, Taira K, Nagata K. 2006. Involvement of template-activating factor I/SET in transcription of adenovirus early genes as a positive-acting factor. J Virol 80:794-801. http://dx.doi.org/10.1128/JVI.80.2.794-801.2006.
42. Jiang M, Imperiale MJ. 2012. Design stars: how small DNA viruses remodel the host nucleus. Future Virol 7:445-459. http://dx.doi.org/10.2217/fvl.12.38.
43. Schmid M, Speiseder T, Dobner T, Gonzalez RA. 2014. DNA virus replication compartments. J Virol 88:1404-1420. http://dx.doi.org/10.1128/JVI.02046-13.
44. Everett RD. 14 October 2015.The dynamic response of IFI16 and PML nuclear body components to HSV-1 infection. J Virol http://dx.doi.org/10.1128/JVI.02249-15.